Radiology · 2005 · 67 citations · 14 references
DentistryOncologyOral RadiologyDiagnostic RadiologySalivary Gland ImagingSpectroscopyBenign Parotid TumorsBenign Salivary Gland TumorsMagnetic Resonance SpectroscopyMalignant Salivary Gland TumorsSalivary Gland CancerSalivary Glands1D Proton Nuclear Magnetic Resonance SpectroscopyEthics ApprovalMagnetic ResonanceSalivary Duct Tumor ImagingSalivary Gland Tumor DiagnosisSalivary Gland Tumor EvaluationSubmandibular Gland Tumor Imaging
PURPOSE: To prospectively evaluate whether proton magnetic resonance (MR) spectroscopy can be used to characterize salivary gland tumors (SGTs). MATERIALS AND METHODS: Ethics committee approval and informed consent were obtained. Hydrogen 1 ((1)H) MR spectroscopy was performed with echo times of 136 and 272 msec at 1.5 T in both SGTs and normal parotid glands. Spectra were analyzed in the time domain by using prior knowledge in the fitting procedure to obtain peak amplitudes of choline (Cho), creatine (Cr), and unsuppressed water. Mean Cho/Cr and Cho/water ratios for each subgroup of SGTs were obtained, and results were compared by using a nonparametric t test. RESULTS: Successful spectra were acquired in 56 patients (35 men, 21 women; mean age, 56 years) with a total of nine malignant tumors and 47 benign SGTs (24 Warthin tumors, 22 pleomorphic adenomas, one oncocytoma). At an echo time of 136 msec, Cho/Cr ratios were obtained in 26 (47%) of 55 spectra, with a mean value (+/- standard deviation) of 1.73 +/- 0.47, 5.49 +/- 1.86, 3.46 +/- 0.84, and 2.45 for malignant tumors, Warthin tumors, pleomorphic adenomas, and oncocytoma, respectively. Differences were significant between Warthin tumors and pleomorphic adenomas (P = .028) and between benign SGTs and malignant tumors (P < .001). At an echo time of 272 msec, Cho/Cr ratios were obtained in 16 (30%) of 53 spectra, with a mean value of 2.27 +/- 0.69, 6.92 +/- 1.47, and 3.67 +/- 1.23 for malignant tumors, Warthin tumors, and pleomorphic adenomas, respectively. Differences were also significant between Warthin tumors and pleomorphic adenomas (P = .041) and benign SGTs and malignant tumors (P = .004). There was a significant difference in mean Cho/water ratio for Warthin tumors versus pleomorphic adenomas at echo times of 136 msec (P = .003) and 272 msec (P = .002) but not for benign SGTs versus malignant tumors. CONCLUSION: (1)H MR spectroscopy may be used to characterize SGTs, but a larger study is required to validate these initial results.
14
Malignant parotid tumors: clinical use of MR imaging and histologic correlation.
Nicole Freling, W.M. Molenaar, A Vermey et al. · Radiology · 1992 · 213 citations
Josh Star‐Lack, Daniel M. Spielman, Elfar Adalsteinsson et al. · Journal of Magnetic Resonance · 1998 · 117 citations